Metallothionein-I+II in neuroprotection

BioFactors

Volumn 35, Issue 4, 2009, Pages 315-325

  Pedersen, Mie Ø ^a   Jensen, Rikke ^a   Pedersen, Dan S ^a,b   Skjolding, Anders D ^a   Hempel, Casper ^a,c   Maretty, Lasse ^a,c   Penkowa, Milena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Metallothionein; Neurodegenerative disease; Neuroinflammation; Neuroprotection

Indexed keywords

ERYTHROPOIETIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEGALIN; METALLOTHIONEIN I; METALLOTHIONEIN II; CELL SURFACE RECEPTOR; METALLOTHIONEIN; METALLOTHIONEIN RECEPTOR; NEUROPROTECTIVE AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; APOPTOSIS; BRAIN INJURY; DRUG MECHANISM; GLIA; HOST RESISTANCE; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; ANIMAL; BIOSYNTHESIS; BRAIN; DEGENERATIVE DISEASE; DRUG EFFECT; ENCEPHALITIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; BRAIN INJURIES; ENCEPHALITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ERYTHROPOIETIN; HUMANS; LDL-RECEPTOR RELATED PROTEIN 2; METALLOTHIONEIN; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 70449726833     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.44     Document Type: Review

References (107)

1. Braun, W., Vasak, M., Robbins, A. H., Stout, C. D., Wagner, G., Kagi, J. H., and Wuthrich, K. (1992) Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2. Proc. Natl. Acad. Sci. USA 89, 10124-10128.
2. Kagi, J. H., Himmelhoch, S. R., Whanger, P. D., Bethune, J. L., and Vallee, B. L. (1974) Equine hepatic and renal metallothioneins. Purification, molecular weight, amino acid composition, and metal content. J. Biol. Chem. 249, 3537-3542.
3. Hidalgo, J., Aschner, M., Zatta, P., and Vasak, M. (2001) Roles of the metallothionein family of proteins in the central nervous system. Brain. Res. Bull. 55, 133-145.
4. Duncan, K. E., Ngu, T. T., Chan, J., Salgado, M. T., Merrifield, M. E., and Stillman, M. J. (2006) Peptide folding, metal-binding mechanisms, and binding site structures in metallothioneins. Exp. Biol. Med. (Maywood) 231, 1488-1499.
5. Feng, W., Benz, F. W., Cai, J., Pierce, W. M., and Kang, Y. J. (2006) Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J. Biol. Chem. 281, 681-687.
6. Pearce, L. L., Gandley, R. E., Han, W., Wasserloos, K., Stitt, M., Kanai, A. J., McLaughlin, M. K., Pitt, B. R., and Levitan, E. S. (2000) Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein. Proc. Natl. Acad. Sci. USA 97, 477-482.
7. Zangger, K., Shen, G., Oz, G., Otvos, J. D., and Armitage, I. M. (2001) Oxidative dimerization in metallothionein is a result of intermolecular disulphide bonds between cysteines in the alpha-domain. Biochem. J. 359, 353-360.
8. Cox, D. R. and Palmiter, R. D. (1983) The metallothionein-I gene maps to mouse chromosome 8: implications for human Menkes' disease, Hum. Genet. 64, 61-64.
9. Karin, M., Eddy, R. L., Henry, W. M., Haley, L. L., Byers, M. G., and Shows, T. B. (1984) Human metallothionein genes are clustered on chromosome 16. Proc. Natl. Acad. Sci. USA 81, 5494-5498.
10. Palmiter, R. D., Findley, S. D., Whitmore, T. E., and Durnam, D. M. (1992) MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA 89, 6333-6337.
11. Quaife, C. J., Findley, S. D., Erickson, J. C., Froelick, G. J., Kelly, E. J., Zambrowicz, B. P., and Palmiter, R. D. (1994) Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33, 7250-7259.
12. Stennard, F. A., Holloway, A. F., Hamilton, J., and West, A. K. (1994) Characterisation of six additional human metallothionein genes. Biochim. Biophys. Acta. 1218, 357-365.
13. West, A. K., Stallings, R., Hildebrand, C. E., Chiu, R., Karin, M., and Richards, R. I. (1990) Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8, 513-518.
14. Coyle, P., Philcox, J. C., Carey, L. C., and Rofe, A. M. (2002) Metallothionein: the multipurpose protein. Cell Mol. Life. Sci. 59, 627-647.
15. Penkowa, M. (2006) Metallothioneins are multipurpose neuroprotectants during brain pathology. FEBS J. 273, 1857-1870.
16. Haq, F., Mahoney, M., and Koropatnick, J. (2003) Signaling events for metallothionein induction. Mutat. Res. 533, 211-226.
17. Miles, A. T., Hawksworth, G. M., Beattie, J. H., and Rodilla, V. (2000) Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 35, 35-70.
18. Penkowa, M. and Moos, T. (1995) Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes. Glia 13, 217-227.
19. Penkowa, M. (2006) Metallothionein I+II expression and roles during neuropathology in the CNS. Dan. Med. Bull. 53, 105-121.
20. Penkowa, M., Caceres, M., Borup, R., Nielsen, F. C., Poulsen, C. B., Quintana, A., Molinero, A., Carrasco, J., Florit, S., Giralt, M., and Hidalgo, J. (2006) Novel roles for metallothionein-I+II (MT-I+II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I+II knockout mice. J. Neurosci. Res. 84, 1452-1474.
21. Penkowa, M., Giralt, M., Thomsen, P. S., Carrasco, J., and Hidalgo, J. (2001) Zinc or copper deficiency-induced impaired inflammatory response to brain trauma may be caused by the concomitant metallothionein changes, J. Neurotrauma 18, 447-463.
22. Penkowa, M., Tio, L., Giralt, M., Quintana, A., Molinero, A., Atrian, S., Vasak, M., and Hidalgo, J. (2006) Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury. J. Neurosci. Res. 83, 974-984.
23. Penkowa, M., Carrasco, J., Giralt, M., Moos, T., and Hidalgo, J. (1999) CNS wound healing is severely depressed in metallothionein I- and II-deficient mice. J. Neurosci. 19, 2535-2545.
24. Penkowa, M., Carrasco, J., Giralt, M., Molinero, A., Hernandez, J., Campbell, I. L., and Hidalgo, J. (2000) Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein- I+II deficient mice. J. Cereb. Blood Flow. Metab. 20, 1174-1189.
25. Giralt, M., Penkowa, M., Lago, N., Molinero, A., and Hidalgo, J. (2002) Metallothionein-1+2 protect the CNS after a focal brain injury. Exp. Neurol. 173, 114-128.
26. Chung, R. S., Adlard, P. A., Dittmann, J., Vickers, J. C., Chuah, M. I., and West, A. K. (2004) Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J. Neurochem. 88, 454-461.
27. Chung, R. S., Hidalgo, J., and West, A. K. (2008) New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J. Neurochem. 104, 14-20.
28. Kohler, L. B., Berezin, V., Bock, E., and Penkowa, M. (2003) The role of metallothionein II in neuronal differentiation and survival. Brain Res. 992, 128-136.
29. Ambjorn, M., Asmussen, J. W., Lindstam, M., Gotfryd, K., Jacobsen, C., Kiselyov, V. V., Moestrup, S. K., Penkowa, M., Bock, E., and Berezin, V. (2008) Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J. Neurochem. 104, 21-37.
30. Chung, R. S., Penkowa, M., Dittmann, J., King, C. E., Bartlett, C., Asmussen, J. W., Hidalgo, J., Carrasco, J., Leung, Y. K., Walker, A. K., Fung, S. J., Dunlop, S. A., Fitzgerald, M., Beazley, L. D., Chuah, M. I., Vickers, J. C., and West, A. K. (2008) Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem. 283, 15349-15358.
31. Penkowa, M., Giralt, M., Camats, J., and Hidalgo, J. (2002) Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. J. Comp. Neurol. 444, 174-189.
32. Penkowa, M. and Hidalgo, J. (2000) Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia. 32, 247-263.
33. Chung, R. S., Vickers, J. C., Chuah, M. I., and West, A. K. (2003) Metallothionein- IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J. Neurosci. 23, 3336-3342.
34. Penkowa, M. and Hidalgo, J. (2001) Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE). Exp. Neurol. 170, 1-14.
35. Penkowa, M., Espejo, C., Martinez-Caceres, E. M., Poulsen, C. B., Montalban, X., and Hidalgo, J. (2001) Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119, 248-260.
36. Comi, C., Leone, M., Bonissoni, S., DeFranco, S., Bottarel, F., Mezzatesta, C., Chiocchetti, A., Perla, F., Monaco, F., and Dianzani, U. (2000) Defective T cell fas function in patients with multiple sclerosis. Neurology 55, 921-927.
37. Huang, W. X., Huang, M. P., Gomes, M. A., and Hillert, J. (2000) Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology 55, 928-934.
38. Segal, B. M. and Cross, A. H. (2000) Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination. Neurology 55, 906-907.
39. Cherian, M. G. and Kang, Y. J. (2006) Metallothionein and liver cell regeneration. Exp. Biol. Med. (Maywood.) 231, 138-144.
40. Masters, B. A., Kelly, E. J., Quaife, C. J., Brinster, R. L., and Palmiter, R. D. (1994) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA 91, 584-588.
41. Fitzgerald, M., Nairn, P., Bartlett, C. A., Chung, R. S., West, A. K., and Beazley, L. D. (2007) Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp. Brain Res. 183, 171-180.
42. Christensen, E. I. and Birn, H. (2001) Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am. J. Physiol. Renal. Physiol. 280, F562-F573.
43. Christensen, E. I. and Birn, H. (2002) Megalin and cubilin: multifunctional endocytic receptors. Nat. Rev. Mol. Cell Biol. 3, 256-266.
44. Moestrup, S. K., Gliemann, J., and Pallesen, G. (1992) Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptorrelated protein in human tissues. Cell. Tissue Res. 269, 375-382.
45. Zheng, G., Bachinsky, D. R., Stamenkovic, I., Strickland, D. K., Brown, D., Andres, G., and McCluskey, R. T. (1994) Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42, 531-542.
46. Campana, W. M., Li, X., Dragojlovic, N., Janes, J., Gaultier, A., and Gonias, S. L. (2006) The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. J. Neurosci. 26, 11197-11207.
47. Czekay, R. P., Orlando, R. A., Woodward, L., Lundstrom, M., and Farquhar, M. G. (1997) Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes. Mol. Biol. Cell 8, 517-532.
48. Fisher, C. E. and Howie, S. E. (2006) The role of megalin (LRP-2/ Gp330) during development. Dev. Biol. 296, 279-297.
49. Futakawa, N., Kondoh, M., Ueda, S., Higashimoto, M., Takiguchi, M., Suzuki, S., and Sato, M. (2006) Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors. Biol. Pharm. Bull. 29, 2016-2020.
50. Theocharis, S. E., Margeli, A. P., Klijanienko, J. T., and Kouraklis, G. P. (2004) Metallothionein expression in human neoplasia. Histopathology 45, 103-118.
51. Kelly, E. J. and Palmiter, R. D. (1996) A murine model of Menkes disease reveals a physiological function of metallothionein. Nat. Genet. 13, 219-222.
52. Kelly, E. J., Quaife, C. J., Froelick, G. J., and Palmiter, R. D. (1996) Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutr. 126, 1782-1790.
53. Kondo, Y., Rusnak, J. M., Hoyt, D. G., Settineri, C. E., Pitt, B. R., and Lazo, J. S. (1997) Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol. 52, 195-201.
54. Michalska, A. E. and Choo, K. H. (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. USA 90, 8088-8092.
55. Cai, L. and Cherian, M. G. (2003) Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copperor cadmium-metallothioneins. Toxicol. Lett. 136, 193-198.
56. Formigari, A., Irato, P., and Santon, A. (2007) Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 146, 443-459.
57. Abel, J. and de Ruiter, N. (1989) Inhibition of hydroxyl-radical- generated DNA degradation by metallothionein. Toxicol. Lett. 47, 191-196.
58. Ghoshal, K., Majumder, S., Li, Z., Bray, T. M., and Jacob, S. T. (1999) Transcriptional induction of metallothionein-I and -II genes in the livers of Cu,Zn-superoxide dismutase knockout mice. Biochem. Biophys. Res. Commun. 264, 735-742.
59. Tamai, K. T., Gralla, E. B., Ellerby, L. M., Valentine, J. S., and Thiele, D. J. (1993) Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA 90, 8013-8017.
60. Haidara, K., Moffatt, P., and Denizeau, F. (1999) Metallothionein induction attenuates the effects of glutathione depletors in rat hepatocytes. Toxicol. Sci. 49, 297-305.
61. Andrews, G. K. (2000) Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59, 95-104.
62. Kondoh, M., Inoue, Y., Atagi, S., Futakawa, N., Higashimoto, M., and Sato, M. (2001) Specific induction of metallothionein synthesis by mitochondrial oxidative stress. Life Sci. 69, 2137-2146.
63. Stankovic, R. K., Chung, R. S., and Penkowa, M. (2007) Metallothioneins I and II: neuroprotective significance during CNS pathology. Int. J. Biochem. Cell Biol. 39, 484-489.
64. Penkowa, M., Florit, S., Giralt, M., Quintana, A., Molinero, A., Carrasco, J., and Hidalgo, J. (2005) Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J. Neurosci. Res. 79, 522-534.
65. Bell, S. G. and Vallee, B. L. (2009) The metallothionein/thionein system: an oxidoreductive metabolic zinc link. Chembiochem. 10, 55-62.
66. Maret, W. (2008) Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp. Gerontol. 43, 363-369.
67. Feng, W., Cai, J., Pierce, W. M., Franklin, R. B., Maret, W., Benz, F. W., and Kang, Y. J. (2005) Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem. Biophys. Res. Commun. 332, 853-858.
68. Singh, K. K., Desouki, M. M., Franklin, R. B., and Costello, L. C. (2006) Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer 5, 14.
69. Maret, W. (2004) Zinc and sulfur: a critical biological partnership. Biochemistry 43, 3301-3309.
70. Kang, Y. J. (2006) Metallothionein redox cycle and function. Exp. Biol. Med. (Maywood) 231, 1459-1467.
71. Maret, W. (2000) The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr., 130, 1455S-1458S.
72. Maret, W. (1995) Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem. Int. 27, 111-117.
73. Cai, L., Wang, Y., Zhou, G., Chen, T., Song, Y., Li, X., and Kang, Y. J. (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 48, 1688-1697.
74. Doering, P., Danscher, G., Larsen, A., Bruhn, M., Sondergaard, C., and Stoltenberg, M. (2007) Changes in the vesicular zinc pattern following traumatic brain injury. Neuroscience 150, 93-103.
75. Mann, J. J. and Fraker, P. J. (2005) Zinc pyrithione induces apoptosis and increases expression of Bim. Apoptosis 10, 369-379.
76. Tekur, S. and Ho, S. M. (2002) Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines. Mol. Carcinog. 33, 44-55.
77. Hainaut, P. and Mann, K. (2001) Zinc binding and redox control of p53 structure and function. Antioxid. Redox. Signal. 3, 611-623.
78. Meplan, C., Richard, M. J., and Hainaut, P. (2000) Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19, 5227-5236.
79. Ostrakhovitch, E. A., Olsson, P. E., Jiang, S., and Cherian, M. G. (2006) Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett. 580, 1235-1238.
80. Ostrakhovitch, E. A., Olsson, P. E., Hofsten von, J., and Cherian, M. G. (2007) P53 mediated regulation of metallothionein transcription in breast cancer cells. J. Cell Biochem. 102, 1571-1583.
81. Lenzlinger, P. M., Morganti-Kossmann, M. C., Laurer, H. L., and McIntosh, T. K. (2001) The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 24, 169-181.
82. Lucas, S. M., Rothwell, N. J., and Gibson, R. M. (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (Suppl 1), S232-S240.
83. Nair, A., Frederick, T. J., and Miller, S. D. (2008) Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65, 2702-2720.
84. Sofroniew, M. V. (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400-407.
85. Correa-Cerro, L. S. and Mandell, J. W. (2007) Molecular mechanisms of astrogliosis: new approaches with mouse genetics. J. Neuropathol. Exp. Neurol. 66, 169-176.
86. Soto, I., Rosenthal, J. J., Blagburn, J. M., and Blanco, R. E. (2006) Fibroblast growth factor 2 applied to the optic nerve after axotomy up-regulates BDNF and TrkB in ganglion cells by activating the ERK and PKA signaling pathways. J. Neurochem. 96, 82-96.
87. Hisaoka, K., Maeda, N., Tsuchioka, M., and Takebayashi, M. (2008) Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production. Brain Res. 1196, 53-58.
88. Kanda, N., Koike, S., and Watanabe, S. (2005) Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes. J. Pharmacol. Exp. Ther. 315, 796-804.
89. Peng, C. H., Huang, C. N., Hsu, S. P. and Wang, C. J. (2007) Penta-acetyl geniposide-induced apoptosis involving transcription of NGF/p75 via MAPK-mediated AP-1 activation in C6 glioma cells. Toxicology 238, 130-139.
90. Dhandapani, K. M., Khan, M. M., Wade, F. M., Wakade, C., Mahesh, V. B., and Brann, D. W. (2007) Induction of transforming growth factorbeta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation, J. Neurosci. Res., 85, 1033-1045.
91. Akiyama, H., Tanaka, T., Maeno, T., Kanai, H., Kimura, Y., Kishi, S., and Kurabayashi, M. (2002) Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells. Invest. Ophthalmol. Vis. Sci. 43, 1367-1374.
92. Tanaka, T., Kanai, H., Sekiguchi, K., Aihara, Y., Yokoyama, T., Arai, M., Kanda, T., Nagai, R., and Kurabayashi, M. (2000) Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J. Mol. Cell Cardiol. 32, 1955-1967.
93. Metsis, M. (2001) Genes for neurotrophic factors and their receptors: structure and regulation. Cell Mol. Life Sci. 58, 1014-1020.
94. Marzella, P. L., Gillespie, L. N., Clark, G. M., Bartlett, P. F., and Kilpatrick, T. J. (1999) The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro. Hear Res. 138, 73-80.
95. Xiao, Z., Kong, Y., Yang, S., Li, M., Wen, J., and Li, L. (2007) Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation. Cell Res. 17, 73-79.
96. Marzella, P. L., Clark, G. M., Shepherd, R. K., Bartlett, P. F., and Kilpatrick, T. J. (1998) Synergy between TGF-beta 3 and NT-3 to promote the survival of spiral ganglia neurones in vitro. Neurosci. Lett. 240, 77-80.
97. Krieglstein, K., Farkas, L., and Unsicker, K. (1998) TGF-beta regulates the survival of ciliary ganglionic neurons synergistically with ciliary neurotrophic factor and neurotrophins. J. Neurobiol. 37, 563-572.
98. Joshi, B., Ordonez-Ercan, D., Dasgupta, P., and Chellappan, S. (2005) Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors. Oncogene 24, 2204-2217.
99. Miyashita, H., and Sato, Y. (2005) Metallothionein 1 is a downstream target of vascular endothelial zinc finger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis. Endothelium 12, 163-170.
100. Sato, M. and Kondoh, M. (2002) Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 196, 9-22.
101. Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., and Cerami, A. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526-10531.
102. Maiese, K., Li, F., and Chong, Z. Z. (2005) New avenues of exploration for erythropoietin. JAMA 293, 90-95.
103. Rabie, T. and Marti, H. H. (2008) Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) 23, 263-274.
104. Abdel-Mageed, A. B., Zhao, F., Rider, B. J., and Agrawal, K. C. (2003) Erythropoietin-induced metallothionein gene expression: role in proliferation of K562 cells. Exp. Biol. Med. (Maywood.) 228, 1033-1039.
105. Wakida, K., Shimazawa, M., Hozumi, I., Satoh, M., Nagase, H., Inuzuka, T., and Hara, H. (2007) Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience 148, 105-114.
106. Liu, X. B., Wang, J. A., Yu, S. P., Keogh, C. L., and Wei, L. (2008) Therapeutic strategy of erythropoietin in neurological disorders. CNS Neurol. Disord. Drug. Targets 7, 227-234.
107. West, A. K., Hidalgo, J., Eddins, D., Levin, E. D., and Aschner, M. (2008) Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology 29, 489-503.